A Study to Evaluate the Pharmacokinetics of Intranasal Esketamine Administered With and Without a Nasal Guide on the Intranasal Device
Clinical trial NCT02060929 · COMPLETED
Trial details
- NCT number
- NCT02060929
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-01-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.